Drug
Treprostinil (Tyvaso® & Tyvaso DPI™)
Status:
To Patients
Condition:
Pulmonary Hypertension
Intervention Type:
Inhaled Drug
Funder Type:
Industry
Drug Details
TYVASO® (treprostinil) Inhalation Solution and TYVASO DPI™ (treprostinil) Inhalation Powder are both a prostacyclin mimetic indicated for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) and pulmonary arterial hypertension (PAH; WHO Group 1) to improve exercise ability.